The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency
This office will be the central hub for all operations related to companies ethical pharmaceutical business
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Accelerating sustainability in Indian pharma industry
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
Subscribe To Our Newsletter & Stay Updated
